FDA Blocks Approval for Libido Patch

  • Playlist
  • Download
  • Embed
    Embed <iframe src="http://www.npr.org/player/embed/4200171/4200172" width="100%" height="290" frameborder="0" scrolling="no">
  • Transcript

A Food and Drug Administration advisory committee has recommended further research on Intrinsa, a skin patch to increase women's sex drives. Critics worry about breast cancer risks associated with the treatment. NPR's Joanne Silberner reports.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.